"Drug Carriers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.
| Descriptor ID |
D004337
|
| MeSH Number(s) |
D26.255.260 E02.319.300.380
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Carriers".
Below are MeSH descriptors whose meaning is more specific than "Drug Carriers".
This graph shows the total number of publications written about "Drug Carriers" by people in this website by year, and whether "Drug Carriers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 16 | 16 |
| 1995 | 1 | 11 | 12 |
| 1996 | 1 | 6 | 7 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 5 | 5 |
| 2001 | 0 | 6 | 6 |
| 2002 | 1 | 6 | 7 |
| 2003 | 0 | 8 | 8 |
| 2004 | 2 | 1 | 3 |
| 2005 | 2 | 4 | 6 |
| 2006 | 2 | 1 | 3 |
| 2007 | 5 | 5 | 10 |
| 2008 | 5 | 1 | 6 |
| 2009 | 1 | 1 | 2 |
| 2010 | 5 | 1 | 6 |
| 2011 | 8 | 4 | 12 |
| 2012 | 6 | 3 | 9 |
| 2013 | 2 | 3 | 5 |
| 2014 | 9 | 2 | 11 |
| 2015 | 4 | 4 | 8 |
| 2016 | 7 | 2 | 9 |
| 2017 | 5 | 4 | 9 |
| 2018 | 1 | 3 | 4 |
| 2019 | 3 | 1 | 4 |
| 2020 | 2 | 3 | 5 |
| 2021 | 1 | 2 | 3 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Carriers" by people in Profiles.
-
Uptake of surface-functionalized thermo-responsive polymeric nanocarriers in corticospinal tract motor neurons. Biochem Biophys Res Commun. 2024 Feb 12; 696:149503.
-
Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer. Colloids Surf B Biointerfaces. 2024 Jan; 233:113631.
-
Redox-active polyphenol nanoparticles deprive endogenous glutathione of electrons for ROS generation and tumor chemodynamic therapy. Acta Biomater. 2023 12; 172:423-440.
-
Stimuli-sensitive drug delivery systems for site-specific antibiotic release. Drug Discov Today. 2022 06; 27(6):1698-1705.
-
A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver. Drug Deliv. 2021 Dec; 28(1):240-251.
-
Treatment of Early Deep Wound Infections after Arterial Reconstructions: A Meta-Analysis and Survey. Ann Vasc Surg. 2021 Jul; 74:356-366.
-
Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy. J Immunother Cancer. 2021 02; 9(2).
-
Safe and effective aerosolization of in vitro transcribed mRNA to the respiratory tract epithelium of horses without a transfection agent. Sci Rep. 2021 01 11; 11(1):371.
-
Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation. Sci Adv. 2020 08; 6(35):eabb7878.
-
RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC. Theranostics. 2020; 10(18):7974-7992.